News & events

Riccardo Natoli clear vision research erythrosight

ANU researchers seek funding to expedite a clinic-ready product for AMD

22 February 2024

Team ErythroSight seeks experts with pharmaceutical experience in therapeutic development and potential licensing deals for collaboration.
JCSMR Honours and HDR Graduates December 2023

Seasons bring more reason to celebrate!

11 December 2023

Thirteen PhD and 26 Honours students completed their academic research and graduated from JCSMR this December 2023.
Erythrosight Clear Vision Research Riccardo Natoli

ErythroSight gets major boost to develop a novel therapeutic and manufacturing pipeline for AMD

8 December 2023

The ErythroSight team has developed a novel therapeutic and manufacturing pipeline that harnesses red blood cell extracellular vesicles to treat retinal degenerations such as age-related macular degeneration (AMD), one of the leading causes of incurable blindness in the developed world.

Pages

Ehsan Arabzadeh Eccles JCSMR

Professor Ehsan Arabzadeh - The Eccles Institute of Neuroscience

12pm 15 Mar 2024
Professor Ehsan Arabzadeh will present 'Deciphering the language of brain cells: what can we learn from neuronal representations?'